2-Norbornanol, 1,3,3-trimethyl-, acetate
Common Name: |
2-Norbornanol, 1,3,3-trimethyl-, acetate |
IUPAC Name: |
[(1S,4R)-1,3,3-trimethyl-2-bicyclo[2.2.1]heptanyl] acetate |
Molecular Formula: |
C12H20O2 |
SMILES: |
CC(=O)OC1C(C2CCC1(C2)C)(C)C |
Inchi: |
1S/C12H20O2/c1-8(13)14-10-11(2,3)9-5-6-12(10,4)7-9/h9-10H,5-7H2,1-4H3/t9-,10?,12+/m1/s1 |
Inchi Key: |
JUWUWIGZUVEFQB-MAZPRZIYSA-N |
Cas No: |
237-588-5 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
196.29 |
Mass (g/mol) |
196.146 |
Molar Refractivity |
56.33 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
2 |
Rings |
2 |
TPSA |
26.30 |
Hetero Atoms |
2 |
Heavy Atoms |
14 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
220.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.117 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.92 |
LogP |
2.764 |
iLOGP |
2.51 |
XLOGP3 |
3.74 |
WLOGP |
2.76 |
MLOGP |
2.76 |
ESOL Log S |
-3.28 |
ESOL Solubility (mg/ml) |
0.103 |
ESOL Solubility (mol/l) |
0.001 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.98 |
Ali Solubility (mg/ml) |
0.02 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.58 |
Silicos-IT Solubility (mg/ml) |
0.52 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.84 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.759 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.658 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |